GOVX
GOVX
NASDAQ · Biotechnology

Geovax Labs Inc

$1.40
-0.01 (-0.71%)
As of Mar 29, 11:03 PM ET ·
Financial Highlights (FY 2026)
Revenue
42.68M
Net Income
-269,757,289
Gross Margin
25.0%
Profit Margin
-632.0%
Rev Growth
+117.3%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 25.0% 56.0% 56.0% 56.0%
Operating Margin -635.8% -4.6% -4.4% -3.9%
Profit Margin -632.0% -4.0% -4.1% -4.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 42.68M 586.6K 551.3K 523.6K
Gross Profit 10.67M 328.2K 308.5K 293.0K
Operating Income -271,399,781 -27,171 -24,446 -20,675
Net Income -269,757,289 -23,280 -22,798 -22,545
Gross Margin 25.0% 56.0% 56.0% 56.0%
Operating Margin -635.8% -4.6% -4.4% -3.9%
Profit Margin -632.0% -4.0% -4.1% -4.3%
Rev Growth +117.3% +23.9% +11.9% +23.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 688.2K 727.8K 639.2K
Total Equity 1.95M 1.96M 1.82M
D/E Ratio 0.35 0.37 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -270,368,438 -32,929 -31,435 -27,673
Free Cash Flow -20,426 -16,844 -21,611